Review summary
Teaching objective: High-risk prenatal care for a 37-year-old woman in her fourteenth pregnancy, conceived about five and a half months after her last birth, following ACOG Obstetric Care Consensus No. 11 (pregnancy at 35 or older), ACOG Practice Bulletin 183 and the WHO 2012 and 2017 recommendations on postpartum hemorrhage, and the WOMAN trial: dating by ultrasound when the last period is unknown, aneuploidy screening offered (cell-free DNA and nuchal translucency), blood group and antibodies, iron deficiency anemia with a hemoglobinopathy screen, oral then intravenous iron and anemia corrected before delivery, early and routine screening for gestational diabetes, blood pressure and low-dose aspirin for preeclampsia risk (USPSTF 2021), placental location and the low risk of placenta accreta without a uterine scar, asymptomatic bacteriuria and cystitis in pregnancy, travel in pregnancy, and a postpartum hemorrhage risk assessment and plan (delivery in a hospital with a blood bank and surgical capability, active management of the third stage with oxytocin, quantitative blood loss, and tranexamic acid within 3 hours of birth if hemorrhage occurs), with counseling, in her own terms, about contraception and the interval before any future pregnancy. The episode ends at 34 weeks, before delivery.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| 27 April 1593 | Born Arjumand Banu Begum in Agra. | CLM-0001, CLM-0002 |
| 10 May 1612 | Marries Prince Khurram and receives the title Mumtaz Mahal. | CLM-0003, CLM-0004 |
| 1613 to 1630 | Thirteen children born; six die in infancy or early childhood; she travels with the court on campaign. | CLM-0006, CLM-0007, CLM-0005 |
| 23 April 1630 | Her thirteenth child, a daughter, is born. | CLM-0008 |
| 1040 AH, from August 1630 | The court is at Burhanpur in the Deccan during a famine. | CLM-0009 |
| 17 June 1631 (17 Dhu al-Qa'da 1040 AH) | Dies at Burhanpur in childbirth with her fourteenth child, a daughter, after a long labor; the cause is given later as postpartum hemorrhage. | CLM-0010, CLM-0011, CLM-0012, CLM-0013, CLM-0015 |
| December 1631 | Her body is moved from Burhanpur to Agra; the Taj Mahal is built as her tomb. | CLM-0014 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | She was born Arjumand Banu Begum in Agra in April 1593; an encyclopedia, citing a seventeenth-century court history, gives 27 April 1593. No Hijri birth date was found in the sources read. |
confirmed | Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) supports Mumtaz Mahal supports |
| D | Her father, Abu'l-Hasan Asaf Khan, was a Persian noble; his sister was the Empress Nur Jahan, wife of the emperor Jahangir. Her mother's family came from Qazvin in Persia. | confirmed | Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) supports Mumtaz Mahal supports |
| D | She was betrothed to Prince Khurram, later the emperor Shah Jahan, in 1607, and married him on 10 May 1612; he gave her the title Mumtaz Mahal, rendered as 'Chosen One of the Palace' or 'the Exalted One of the Palace'. | confirmed | Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) supports Mumtaz Mahal supports |
| D | She was a Shi'a Muslim. | confirmed | Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) supports Mumtaz Mahal supports |
| D | Despite her frequent pregnancies, she travelled with her husband's entourage on his military campaigns. | confirmed | Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) supports |
| D | Her first thirteen children were born between 1613 and 1630: Hur-ul-Nisa (1613), Jahanara (1614), Dara Shikoh (1615), Shah Shuja (1616), Roshanara (1617), Aurangzeb (1618), Izad Bakhsh (1619), Surayya Banu (1621), a son who died soon after birth (1622), Murad Bakhsh (1624), Lutf Allah (1626), Daulat Afza (1628), and Husn Ara (1630). Thirteen births before 1631 in the encyclopedia's table; the state tourism page omits the son who died in 1622 (CLM-0012). |
probable | Mumtaz Mahal supports Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) supports |
| D | Six of her children died in infancy or early childhood before 1631: Hur-ul-Nisa at three and Surayya Banu at seven, both of smallpox; Izad Bakhsh in infancy; a son soon after birth in 1622; Lutf Allah at about eighteen months; and Daulat Afza in infancy. Causes are given only for the two deaths from smallpox. |
probable | Mumtaz Mahal supports Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) supports |
| D | Her thirteenth child, Husn Ara, was born on 23 April 1630. | probable | Mumtaz Mahal supports Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) supports |
| D | In the year 1040 AH (from August 1630) the emperor was in the Deccan with the court at Burhanpur, during a severe famine in the Deccan and Gujarat, when he ordered soup kitchens and weekly alms for as long as he remained at Burhanpur. Her presence with the court at Burhanpur is documented by her death there (CLM-0010). |
confirmed | Elliot HM, Dowson J, editors. The History of India as Told by Its Own Historians: The Muhammadan Period, Volume VII. London: Trubner; 1877. Includes extracts from the Badshah-nama of Abdu-l Hamid Lahori supports |
| D | The court chronicler Abdul Hamid Lahori recorded that on 17 Zi-l ka'da 1040 AH she died, in the fortieth year of her age, to the great grief of her husband, having borne him eight sons and six daughters; the translators note that she died in childbirth. The date corresponds to 17 June 1631 in the Gregorian calendar, at Burhanpur, giving birth to a daughter, Gauhar Ara. The fortieth year is counted in lunar (Hijri) years; by the Gregorian calendar she was 38. |
confirmed | Elliot HM, Dowson J, editors. The History of India as Told by Its Own Historians: The Muhammadan Period, Volume VII. London: Trubner; 1877. Includes extracts from the Badshah-nama of Abdu-l Hamid Lahori supports Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) supports Mumtaz Mahal supports Longstaff A. Calendars from around the world context |
| D | Later accounts state that she died after a prolonged labor of about 30 hours with her fourteenth child. Reported by an encyclopedia citing a 2014 case report and a seventeenth-century court history; the primary text was not read. |
probable | Mumtaz Mahal supports |
| D | The state tourism page for the Taj Mahal calls Gauhar Ara her thirteenth child and lists thirteen children, while the court chronicle counts fourteen (eight sons and six daughters). The count of fourteen is preferred; the thirteen-child list omits the son who died soon after birth in 1622. |
disputed | Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) supports Elliot HM, Dowson J, editors. The History of India as Told by Its Own Historians: The Muhammadan Period, Volume VII. London: Trubner; 1877. Includes extracts from the Badshah-nama of Abdu-l Hamid Lahori disputes |
| R | Her death is attributed to postpartum hemorrhage. A retrospective medical reading of a death in childbirth after a long labor; no contemporary description of bleeding was read. |
probable | Mumtaz Mahal supports |
| D | Her fourteenth child, Gauhar Ara, was born on 17 June 1631, about fourteen months after Husn Ara. If the last pregnancy went to term, it began about five months after the previous birth. |
probable | Mumtaz Mahal supports Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) supports Elliot HM, Dowson J, editors. The History of India as Told by Its Own Historians: The Muhammadan Period, Volume VII. London: Trubner; 1877. Includes extracts from the Badshah-nama of Abdu-l Hamid Lahori supports |
| D | She was first buried at Burhanpur in the walled Zainabad garden on the Tapti River; her body was moved to Agra in December 1631, and the Taj Mahal was built as her tomb over more than twenty years. | confirmed | Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) supports Mumtaz Mahal supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Fourteenth pregnancy at 37 (gravida 14, para 13), single live intrauterine pregnancy dated by ultrasound at 13 weeks 2 days; estimated due date July 12 | active | confirmed | both_with_link | CLM-0006, CLM-0008, CLM-0010, CLM-0015 |
| S | Grand multiparity: thirteen previous vaginal births, no cesarean or other uterine surgery; seven living children | active | confirmed | both_with_link | CLM-0006, CLM-0012, CLM-0007 |
| S | Short interpregnancy interval: conception about five and a half months after her last birth | active | confirmed | active | CLM-0008, CLM-0015 |
| S | Iron deficiency anemia in pregnancy: hemoglobin 10.1 g/dL, MCV 76 fL, ferritin 9 ng/mL | active | confirmed | active | CLM-0006, CLM-0008 |
| S | Acute cystitis in pregnancy at 24 weeks: dysuria and frequency, no fever or flank pain; urine culture grew Escherichia coli sensitive to nitrofurantoin; treated and resolved | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-01-06 | Hemoglobin [Mass/volume] in Blood | 10.1 g/dL (low) Reference 11-15 g/dL |
http://loinc.org · 718-7 |
| S | 2026-01-06 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 76 fL (low) Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 2026-01-06 | Leukocytes [#/volume] in Blood by Automated count | 8.6 10*3/uL Reference 4-13 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-01-06 | Platelets [#/volume] in Blood by Automated count | 245 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-01-06 | Ferritin [Mass/volume] in Serum or Plasma | 9 ng/mL (low) Reference 30-150 ng/mL |
http://loinc.org · 2276-4 |
| S | 2026-01-06 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4% Reference <=5.7% |
http://loinc.org · 4548-4 |
| S | 2026-01-06 | Fetal Crown Rump length US | 72 mm Reference Consistent with 13 weeks 2 days; used for dating because her last period is not known |
http://loinc.org · 11957-8 |
| S | 2026-01-06 | Fetal nuchal translucency measured by US | 1.7 mm Reference <=3.5 mm |
http://loinc.org · 33069-6 |
| S | 2026-01-06 | Total score [EPDS] | 8 | http://loinc.org · 99046-5 |
| S | 2026-02-03 | Hemoglobin [Mass/volume] in Blood | 10.3 g/dL (low) Reference 10.5-15 g/dL |
http://loinc.org · 718-7 |
| S | 2026-02-03 | Ferritin [Mass/volume] in Serum or Plasma | 12 ng/mL (low) Reference 30-150 ng/mL |
http://loinc.org · 2276-4 |
| S | 2026-03-03 | Hemoglobin [Mass/volume] in Blood | 10.9 g/dL Reference 10.5-15 g/dL |
http://loinc.org · 718-7 |
| S | 2026-03-03 | Ferritin [Mass/volume] in Serum or Plasma | 96 ng/mL Reference 30-150 ng/mL |
http://loinc.org · 2276-4 |
| S | 2026-03-03 | Fetal Body weight estimated by US | 410 g Reference About the 50th centile for 21 weeks |
http://loinc.org · 11727-5 |
| S | 2026-04-14 | Hemoglobin [Mass/volume] in Blood | 11.4 g/dL Reference 10.5-15 g/dL |
http://loinc.org · 718-7 |
| S | 2026-04-14 | Ferritin [Mass/volume] in Serum or Plasma | 110 ng/mL Reference 30-150 ng/mL |
http://loinc.org · 2276-4 |
| S | 2026-04-14 | Platelets [#/volume] in Blood by Automated count | 232 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-04-14 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO | 128 mg/dL Reference <=139 mg/dL |
http://loinc.org · 1504-0 |
| S | 2026-04-14 | Total score [EPDS] | 6 | http://loinc.org · 99046-5 |
| S | 2026-06-02 | Hemoglobin [Mass/volume] in Blood | 11.8 g/dL Reference 11-15 g/dL |
http://loinc.org · 718-7 |
| S | 2026-06-02 | Platelets [#/volume] in Blood by Automated count | 228 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-06-02 | Total score [EPDS] | 5 | http://loinc.org · 99046-5 |
| S | 2026-06-02 | Fetal Body weight estimated by US | 2380 g Reference About the 45th centile for 34 weeks |
http://loinc.org · 11727-5 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-01-06 | Body height | 157 cm | 8302-2 | S |
| 2026-01-06 | Body weight | 58.6 kg | 29463-7 | S |
| 2026-01-06 | Body mass index (BMI) [Ratio] | 23.8 kg/m2 | 39156-5 | S |
| 2026-01-06 | Systolic blood pressure | 104 mm[Hg] | 8480-6 | S |
| 2026-01-06 | Diastolic blood pressure | 64 mm[Hg] | 8462-4 | S |
| 2026-01-06 | Heart rate | 84 /min | 8867-4 | S |
| 2026-01-06 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-01-06 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-01-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-02-03 | Body height | 157 cm | 8302-2 | S |
| 2026-02-03 | Body weight | 59.8 kg | 29463-7 | S |
| 2026-02-03 | Body mass index (BMI) [Ratio] | 24.3 kg/m2 | 39156-5 | S |
| 2026-02-03 | Systolic blood pressure | 106 mm[Hg] | 8480-6 | S |
| 2026-02-03 | Diastolic blood pressure | 64 mm[Hg] | 8462-4 | S |
| 2026-02-03 | Heart rate | 86 /min | 8867-4 | S |
| 2026-02-03 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-02-03 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-02-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-03-03 | Body height | 157 cm | 8302-2 | S |
| 2026-03-03 | Body weight | 61.9 kg | 29463-7 | S |
| 2026-03-03 | Body mass index (BMI) [Ratio] | 25.1 kg/m2 | 39156-5 | S |
| 2026-03-03 | Systolic blood pressure | 104 mm[Hg] | 8480-6 | S |
| 2026-03-03 | Diastolic blood pressure | 62 mm[Hg] | 8462-4 | S |
| 2026-03-03 | Heart rate | 88 /min | 8867-4 | S |
| 2026-03-03 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-03-03 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-03-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-03-24 | Body height | 157 cm | 8302-2 | S |
| 2026-03-24 | Body weight | 62.6 kg | 29463-7 | S |
| 2026-03-24 | Body mass index (BMI) [Ratio] | 25.4 kg/m2 | 39156-5 | S |
| 2026-03-24 | Systolic blood pressure | 108 mm[Hg] | 8480-6 | S |
| 2026-03-24 | Diastolic blood pressure | 66 mm[Hg] | 8462-4 | S |
| 2026-03-24 | Heart rate | 92 /min | 8867-4 | S |
| 2026-03-24 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-03-24 | Body temperature | 37.1 Cel | 8310-5 | S |
| 2026-03-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-04-14 | Body height | 157 cm | 8302-2 | S |
| 2026-04-14 | Body weight | 64.6 kg | 29463-7 | S |
| 2026-04-14 | Body mass index (BMI) [Ratio] | 26.2 kg/m2 | 39156-5 | S |
| 2026-04-14 | Systolic blood pressure | 108 mm[Hg] | 8480-6 | S |
| 2026-04-14 | Diastolic blood pressure | 68 mm[Hg] | 8462-4 | S |
| 2026-04-14 | Heart rate | 86 /min | 8867-4 | S |
| 2026-04-14 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-04-14 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-04-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-06-02 | Body height | 157 cm | 8302-2 | S |
| 2026-06-02 | Body weight | 68 kg | 29463-7 | S |
| 2026-06-02 | Body mass index (BMI) [Ratio] | 27.6 kg/m2 | 39156-5 | S |
| 2026-06-02 | Systolic blood pressure | 112 mm[Hg] | 8480-6 | S |
| 2026-06-02 | Diastolic blood pressure | 70 mm[Hg] | 8462-4 | S |
| 2026-06-02 | Heart rate | 88 /min | 8867-4 | S |
| 2026-06-02 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-06-02 | Body temperature | 36.8 Cel | 8310-5 | S |
| 2026-06-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Married for more than thirteen years; seven living children, from nine months to about sixteen years old; six of her children died in infancy or early childhood. She prefers to be addressed as Mumtaz Mahal
- S Practising Shi'a Muslim; prays daily; prefers women clinicians and a chaperone for examinations; speaks Persian, Urdu, and English
- S Travels often and for long stretches with her family and household; arrived in the city two months ago and may travel again in the spring
- S Never smoked; no alcohol; no drug use; feels safe at home; screen for intimate partner violence negative
- S Supports: a large household, her eldest daughter, and a close woman friend who travels with her
- S Breastfed her last baby for five months; her periods had not returned before this pregnancy, so she does not know the date of her last period
Functional status
- S Independent; manages a large household; tired by afternoon and breathless on stairs since the pregnancy began
Mental status
- S Composed, warm, and articulate; mood "tired but glad"; anxious about the pregnancy because of the children she has lost; no thoughts of self-harm; EPDS 8 with item 10 scored 0
Allergies and medications
Allergies
- S No known allergy
Medications
- S Folic acid 0.4 mg oral tablet, one tablet by mouth daily
- S Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day
- S Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtime
- S Nitrofurantoin (monohydrate/macrocrystals) 100 mg oral capsule, one capsule by mouth twice daily for 5 days
- S Ferric carboxymaltose 750 mg in 250 mL 0.9% sodium chloride, intravenous infusion over 15 minutes (first of two doses)
- S Ferric carboxymaltose 750 mg in 250 mL 0.9% sodium chloride, intravenous infusion over 15 minutes (second of two doses)
Procedures and immunizations
Procedures
- S First-trimester ultrasound for dating and nuchal translucency: single live intrauterine fetus, crown-rump length 72 mm (13 weeks 2 days), nuchal translucency 1.7 mm, nasal bone present; placenta posterior; no structural abnormality seen
- S Detailed fetal anatomy ultrasound at 21 weeks 2 days: single fetus, normal anatomy, estimated weight 410 g; placenta posterior and fundal, lower edge more than 5 cm from the internal os; no placental lacunae, normal retroplacental clear zone and myometrial thickness; normal amniotic fluid
- S Third-trimester growth ultrasound at 34 weeks 2 days: cephalic presentation, estimated weight 2380 g (about the 45th centile), normal amniotic fluid, placenta posterior fundal
Immunizations
- S 2026-01-06: Influenza vaccine, 2025-2026 season, given in pregnancy
- S 2026-04-14: Tdap vaccine in pregnancy, 27 weeks
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D 1613 to 1630: Thirteen births between 1613 and 1630, the last in April 1630, while travelling with the court (CLM-0006, CLM-0005)
Family history
- D natural daughter: Eldest daughter died of smallpox in 1616, aged three
- D natural son: A son died in infancy in 1621; cause not recorded in the cited source
- D natural son: A son died soon after birth in 1622; cause not recorded in the cited source
- D natural daughter: A daughter died of smallpox in 1628, aged seven
- D natural son: A son died in 1628 at about eighteen months; cause not recorded in the cited source
- D natural son: A son died in infancy in 1629; cause not recorded in the cited source
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Hemoglobin at least 11 g/dL with replete iron stores before delivery | 2026-06-02 | completed | Hemoglobin 11.8 g/dL and ferritin 110 ng/mL after two doses of intravenous iron |
| An informed choice about aneuploidy screening by 14 weeks | 2026-02-03 | completed | Chose cell-free DNA (low risk) with the nuchal translucency scan (1.7 mm); declined diagnostic testing |
| Blood pressure below 140/90 mmHg with aspirin taken nightly from 13 weeks | 2026-07-12 | active | Blood pressure 104/62 to 112/70 mmHg throughout; aspirin taken nightly |
| A written delivery and postpartum hemorrhage plan agreed by 36 weeks, with birth planned in a hospital with a blood bank and operating theatre | 2026-06-02 | completed | Plan agreed at 34 weeks: induction at 39 weeks at the hospital, oxytocin after birth, quantitative blood loss, and tranexamic acid ready |
| A postpartum contraception choice and a plan for the interval before any future pregnancy, made on her own terms before delivery | 2026-06-02 | completed | Chose an etonogestrel implant before discharge after the birth; plans at least 18 to 24 months before any future pregnancy |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| First prenatal visit: dating and nuchal translucency scan; blood count, ferritin, blood group and antibody screen, rubella immunity, hepatitis B surface antigen, HIV, syphilis, and hepatitis C tests; urine culture for asymptomatic bacteriuria; hemoglobin electrophoresis for microcytosis; hemoglobin A1c as an early diabetes screen; influenza vaccine; folic acid | completed | GL-USPSTF-AB, GL-CDC-PREGVAX, GL-ACOG-AMA-2022 |
| Aneuploidy screening offered, with diagnostic testing available: cell-free DNA and the nuchal translucency measurement today, or chorionic villus sampling or amniocentesis; she chose cell-free DNA | completed | GL-ACOG-ANEU-2020, GL-ACOG-AMA-2022 |
| Maternal-fetal medicine consultation for a fourteenth pregnancy at 37 with a short interpregnancy interval and anemia: surveillance, anemia treatment, placental assessment, delivery timing and place, and postpartum hemorrhage planning | completed | GL-ACOG-AMA-2022, GL-ACOG-PPH-2017 |
| Iron deficiency anemia: ferrous sulfate 325 mg every other day; repeat blood count and ferritin in four weeks, with intravenous iron in the second trimester if she cannot tolerate oral iron or the hemoglobin does not rise; aim for hemoglobin of 11 g/dL or more before delivery | completed | GL-ACOG-ANEMIA-2021 |
| Preeclampsia prevention: aspirin 81 mg at bedtime from 13 weeks until delivery for two moderate risk factors (age 35 or older and a previous adverse pregnancy outcome); blood pressure and urine protein at every visit | completed | GL-USPSTF-ASA-2021 |
| Detailed anatomy scan at 20 to 22 weeks with placental location; if the placenta is low-lying or covers the cervix, a repeat scan at 32 weeks and assessment for placenta accreta spectrum | completed | GL-ACOG-AMA-2022, GL-ACOG-PAS-2018 |
| Gestational diabetes: hemoglobin A1c today because she is of South Asian heritage with a BMI of 23 or more; one-hour glucose challenge at 24 to 28 weeks | completed | GL-ACOG-GDM-2018 |
| Travel: travel is reasonable until about 36 weeks if the pregnancy stays uncomplicated; on long journeys walk every one to two hours, drink plenty, and wear compression stockings; carry her prenatal record; find maternity care where she stays; stay near the delivery hospital from 36 weeks | completed | GL-ACOG-TRAVEL-2018 |
| Postpartum hemorrhage risk assessment at intake and again in the third trimester and on admission for birth (grand multiparity and anemia raise her risk); delivery planned in a hospital with a blood bank, anesthesia, and an operating theatre | completed | GL-ACOG-PPH-2017, GL-WHO-PPH-2012 |
| Mood: EPDS in each trimester, with support for the grief of having lost several children | completed | GL-ACOG-MH-2023 |
| Postpartum hemorrhage plan for birth: induction at 39 weeks in hospital; type and screen and blood count on admission; two large-bore intravenous lines; avoid prolonged labor, with timely assessment of progress; oxytocin 10 units after birth as active management of the third stage; quantitative blood loss; tranexamic acid 1 g intravenously within 3 hours of birth if hemorrhage is diagnosed, with a second 1 g dose if bleeding continues after 30 minutes; second-line uterotonics, a uterine balloon, and the massive transfusion protocol ready | completed | GL-ACOG-PPH-2017, GL-WHO-PPH-2012, GL-WHO-TXA-2017, GL-WOMAN-2017, GL-ACOG-AMA-2022 |
| Contraception and interpregnancy interval, on her own terms: options explained (implant, hormonal or copper IUD, progestin-only pill, lactational amenorrhea, and permanent methods); she chose an etonogestrel implant before discharge after the birth and plans to wait at least 18 to 24 months before any future pregnancy | completed | GL-ACOG-IPC-2019, GL-CDC-USMEC-2024 |
Planned encounters
- 2026-01-06 — First prenatal visit at 13 weeks in a fourteenth pregnancy: dating and nuchal translucency scan, prenatal tests, and a high-risk plan (ENC-001)
- 2026-02-03 — Prenatal visit at 17 weeks, with maternal-fetal medicine consultation (ENC-002)
- 2026-03-03 — Prenatal visit at 21 weeks with the anatomy scan and placental location (ENC-003)
- 2026-03-24 — Same-day sick visit for painful, frequent urination at 24 weeks (ENC-006, unscheduled)
- 2026-04-14 — Prenatal visit at 27 weeks: glucose challenge, blood count, and Tdap (ENC-004)
- 2026-06-02 — Prenatal visit at 34 weeks: growth scan, postpartum hemorrhage risk assessment, delivery plan, and contraception counseling (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Sick Visit
- Progress note 05 — Focused Visit (Follow-up)
- Progress note 06 — Focused Visit (Care-plan review)
- Maternal-Fetal Medicine referral
- Maternal-Fetal Medicine consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Sick Visit (XML)
- Progress note 05 — Focused Visit (Follow-up) (XML)
- Progress note 06 — Focused Visit (Care-plan review) (XML)
- Maternal-Fetal Medicine referral (XML)
- Maternal-Fetal Medicine consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Mumtaz Mahal; About Empress Mumtaz Mahal (Taj Mahal official website) | Department of Tourism, Government of Uttar Pradesh | government |
| SRC-0002 | Elliot HM, Dowson J, editors. The History of India as Told by Its Own Historians: The Muhammadan Period, Volume VII. London: Trubner; 1877. Includes extracts from the Badshah-nama of Abdu-l Hamid Lahori | Internet Archive (india.history.resource.309) | primary |
| SRC-0003 | Mumtaz Mahal | Wikipedia | other |
| SRC-0004 | Longstaff A. Calendars from around the world | Royal Museums Greenwich | other |
| SRC-0005 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check ultrasound dating, the anemia workup and intravenous iron, aspirin indication, placental assessment, cystitis treatment at 24 weeks, the travel deviation, the postpartum hemorrhage plan (oxytocin, quantitative blood loss, tranexamic acid timing and dose), and the contraception counseling. |
| provenance review | not_started | The Badshah-nama of Lahori (Elliot and Dowson, volume VII, 1877), the Uttar Pradesh tourism pages for the Taj Mahal, an encyclopedia article, and a museum paper on calendars logged. Her fourteen children, travel with the court, and death in childbirth at Burhanpur are D; the 30-hour labor is D, probable (secondary); postpartum hemorrhage is R, probable. Encyclopaedia Iranica, Britannica, UNESCO, and Archnet returned HTTP 403 or 429, and Kumar 2014 and Koch 2006 could not be read. |
| safe messaging review | not_started | Her death in childbirth and the deaths of her children are recorded as facts without detail. EPDS scores are below the threshold with item 10 scored 0, so no safety assessment is required. No statement, decision, or health fact is attributed to her husband or children in the modern episode. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.